Intermittent Hypoxia Therapy in Cardiac Rehabilitation

Effect of Intermittent Hypoxia Therapy on Functional Capacity in Geriatric Cardiac Patients With Functional Impairment During a Cardiac Rehabilitation Program: a Pilot Study

This is a randomized control pilot study to assess the effect of intermittent hypoxia therapy on functional capacity vs conventional care in old patients with functional impairment admitted to a Phase 2 in-hospital cardiac rehabilitation program.

Study Overview

• Status: Completed
• Conditions: Cardiovascular Disease; Hypoxia; Exercise
• Intervention / Treatment: Device: Intermittent hypoxia therapy; Other: Conventional phase 2 cardiac rehabilitation programme

Detailed Description

Because the improvement of exercise tolerance reduces mortality in elderly patients affected by cardiovascular disease, intermittent hypoxia therapy (IHT) - defined as repeated episodes of hypoxia interspersed with normoxic periods delivered by an ad hoc device - might be a valuable tool to be associated to structured cardiac rehabilitation (CR) interventions.

The present study is a pilot, monocentric, randomized (randomization ratio 1:1), parallel group study to assess the effect of IHT on functional capacity vs conventional care in old patients with functional impairment admitted to a phase 2 in-hospital cardiac rehabilitation program.

The study will enroll cardiac patients of both genders, ≥ 75 years and with a functional impairment assessed by a Short Physical Performance Battery (SPPB) score < 7.

The effect of IHT on functional capacity will be evaluated on top of the conventional multidisciplinary CR intervention, by means of SPPB score variation; variations in quality of life and cognitive status will also be evaluated as secondary goals of the study.

The total amount of IHT sessions per patient will be 10, 1 per day over 2 weeks, the duration of each single procedure will be 45 min and the Hypoxic O2 conc.% will be 14-10. The study was approved by local ethic committee.

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Italy
  • Pavia, Italy, 27100
    • Istituti Clinici Scientifici Maugeri IRCCS

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 75 years and older (Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Admission to a Phase 2 in-hospital cardiac rehabilitation program because of a recent index event;
• Provision of signed and dated informed consent form;
• Age ≥ 75 years;
• Basic venous blood oxygen saturation (SpO2) level > 93% measured at the fingertip;
• SPPB score < 7;
• New York Heart Association (NYHA) Class I-III.

Exclusion Criteria:

• Inability to give informed consent (diminished understanding or comprehension);
• Age < 75 years;
• SPPB Score ≥ 7;
• NYHA Class IV and/or concomitant i.v. therapy with cardiovascular active drugs;
• Uncontrolled angina pectoris;
• Uncontrolled arterial hypertension;
• Uncontrolled atrial or ventricular arrhythmias;
• Active pericarditis or myocarditis;
• Need of continuous or intermittent O2 therapy;
• Hb < 10 g/dl;
• Severe concomitant non-cardiac diseases such as cancer or any other systemic disease limiting to participate in the study
• Acute inflammatory diseases;
• Acute non-cardiac somatic diseases, or somatic diseases with symptoms of decompensation;
• Currently implanted left ventricular assist device;
• Inability to accept the procedure of breathing via facial mask.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: IHT group; Intermittent hypoxia therapy on top of the conventional phase 2 in-hospital rehabilitation program	Device: Intermittent hypoxia therapy; Intermittent Hypoxic Therapy (further referred to as IHT). A typical IHT session consists of repeated short-term moderate hypoxia (down to 10 vol.% O2), interrupted by brief periods of reoxygenation. These periods of recovery could be either normoxic (21 vol.% O2, Hypoxia-Normoxia mode) or hyperoxic (30-35 vol.% O2, Hypoxia-Hyperoxia mode, further referred to as IHHT). The gas mixtures are supplied to a patient via facial mask.; Other: Conventional phase 2 cardiac rehabilitation programme; The core components of a Phase 2 in-hospital cardiac rehabilitation program include: 1) patient assessment with medical control to promote clinical stabilization and optimization of pharmacologic treatment; 2) physical activity counselling; 3) prescription of an individualized exercise training; 4) diet/nutritional counselling; 5) weight control management; 6) Lipid management; 7) blood pressure monitoring and management; 8) smoking cessation; 9) vocational support; 10) psychosocial management..
Active Comparator: Conventional group; Conventional phase 2 in-hospital rehabilitation program	Other: Conventional phase 2 cardiac rehabilitation programme; The core components of a Phase 2 in-hospital cardiac rehabilitation program include: 1) patient assessment with medical control to promote clinical stabilization and optimization of pharmacologic treatment; 2) physical activity counselling; 3) prescription of an individualized exercise training; 4) diet/nutritional counselling; 5) weight control management; 6) Lipid management; 7) blood pressure monitoring and management; 8) smoking cessation; 9) vocational support; 10) psychosocial management..

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Changes in SPPB score	The Short Physical Performance Battery (SPPB) is a series of physical performance tests used in older persons to assess lower extremity function and mobility. Score total: minimum 0 (lowest performance), maximum 12 (highest performance). Three subscales (minimum 0, maximum 4 points each one): balance test, gait speed test, chair stand test.	30 days

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Changes in distance at the 6-min walking test	6-min walking test is a test for functional evaluation based on walking distance performed by the patient in the time window at the individual walking speed. Score in meters: minimum zero, maximum indefinite	30 days
Changes in peak exercise oxygen uptake (peak VO2)	Peak VO2 represents the maximal individualized oxygen consumption at the peak effort, evaluated by means of cardiopulmonary exercise testing, expressed by means of ml of oxygen per Kg of body weight per minute.	30 days
Changes in basal blood pressure	Expressed by means of mmHg. Indicator of haemodynamic status.	30 days
Changes in basal heart rate	Expressed by means of number of beats per minute. Indicator of haemodynamic status.	30 days
Changes in EuroQoL score	European Quality of Life score (EuroQoL). Score: from 0 (lowest condition) to 10 (best condition).	30 days
Changes in geriatric depression scale	30 items with relative categorization (1 present; 0 absent). Minimum 0 points (absence of depression), maximum 30 point (highest grade of depression).	30 days
Changes in minimental state evaluation	Tool for evaluation of cognitive status in older patients. Minimum score 0 (absence of cognitive impairment), maximum 30 (highest grade of cognitive impairment)	30 days

Collaborators and Investigators

• Sponsor: Istituti Clinici Scientifici Maugeri SpA
• Investigators: Study Chair: Roberto Pedretti, MD, ICS Maugeri care and Research Institute, Pavia, Italy

Study record dates

Study Major Dates

• Study Start (Actual): February 12, 2019
• Primary Completion (Actual): June 30, 2020
• Study Completion (Actual): October 30, 2020

Study Registration Dates

• First Submitted: July 22, 2019
• First Submitted That Met QC Criteria: July 25, 2019
• First Posted (Actual): July 26, 2019

Study Record Updates

• Last Update Posted (Actual): December 15, 2021
• Last Update Submitted That Met QC Criteria: December 14, 2021
• Last Verified: July 1, 2019

More Information

Terms related to this study

• Keywords: exercise; rehabilitation; cardiovascular disease
• Additional Relevant MeSH Terms: Signs and Symptoms, Respiratory; Cardiovascular Diseases; Hypoxia
• Other Study ID Numbers: 2233CE

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No